This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Summary: In this issue of Cancer Discovery, Pennycuick and colleagues comprehensively evaluate the immune contexture of progressive and regressive lesions in squamous pulmonary premalignancy. The authors dissect the molecular features of these lesions and the potential pathways of immune escape operative in progression to invasive cancer.
See related article by Pennycuick et al., p. 1489.
Footnotes
Cancer Discov 2020;10:1442–4
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
October 2020
Volume 10, Issue 10
Volume 10, Issue 10
Immunosurveillance and Regression in the Context of Squamous Pulmonary Premalignancy
Jump to section
Advertisement